Cart
sales@molnova.com
dY-V-G
CAS No. 86030-52-6
dY-V-G( ——— )
Catalog No. M41787 CAS No. 86030-52-6
H-D-Tyr-Val-Gly-OH is a catalyst of the synthesis of phenylhydrazones.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamedY-V-G
-
NoteResearch use only, not for human use.
-
Brief DescriptionH-D-Tyr-Val-Gly-OH is a catalyst of the synthesis of phenylhydrazones.
-
DescriptionH-D-Tyr-Val-Gly-OH is a catalyst of the synthesis of phenylhydrazones.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number86030-52-6
-
Formula Weight337.38
-
Molecular FormulaC16H23N3O5
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Stefanucci A, et al. In Silico Identification of Tripeptides as Lead Compounds for the Design of KOR Ligands. Molecules. 2021 Aug 6;26(16):4767.?
molnova catalog
related products
-
CSP
CSP
-
Deferitazole
Deferitazole (FBS 0701) is a novel and orally active, selective and high affinity iron chelator.
-
AZD0780
AZD0780 (EX-A6975) is an oral small molecule PCSK9 inhibitor being developed by AstraZeneca as a first-in-class treatment for patients with dyslipidemia that is uncontrolled with statins alone.
